Latanoprost Yonsung (Latanoprost)

Latanoprost is a prostaglandin F2α analogue that activates FP receptors in the eye’s ciliary body. This activation remodels extracellular matrix components, enhancing uveoscleral outflow of aqueous humor, which in turn reduces intra‑ocular pressure.

The dosing regimen for Latanoprost Yonsung is determined by the prescribing clinician. Typically, one drop is instilled into the affected eye(s) once daily, often in the evening, but the exact schedule should follow the prescriber’s instructions.

Safety data for Latanoprost Yonsung in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analogue class, which generally offers once‑daily dosing and strong IOP‑lowering efficacy. Compared with alternatives such as timolol (a beta‑blocker) or brimonidine (an alpha‑agonist), prostaglandin analogues often achieve greater pressure reduction with a convenient dosing schedule, though individual response may vary.

Store the ophthalmic solution at room temperature, below 25 °C, in its original container. Protect the bottle from light and moisture, and keep it out of reach of children. Do not freeze the product.

Instill one drop of Latanoprost Yonsung into the affected eye(s) once daily, preferably in the evening. Tilt the head back, pull down the lower eyelid to create a small pocket, and place the drop without touching the tip of the bottle to the eye or lashes.

Serious risks include severe allergic reactions, persistent eye pain, sudden loss of vision, corneal edema or ulceration, and acute anterior uveitis. Patients should seek immediate medical attention if they experience any of these symptoms.

Latanoprost Yonsung should be avoided in individuals with known hypersensitivity to latanoprost or any component of the formulation, active ocular infections, or those who have had recent ocular surgery without physician approval. Caution is also advised for patients with a history of uveitis.